Bausch Health Cos
Bausch Health Companies Inc., commonly referred to as Bausch Health, is a prominent global healthcare company headquartered in Canada. Founded in 2013, the company has rapidly established itself in the pharmaceutical and medical device industries, focusing on eye health, gastrointestinal health, and dermatology. With a diverse portfolio of innovative products, Bausch Health is renowned for its commitment to improving patient outcomes through advanced therapies and technologies. Key offerings include prescription medications, over-the-counter products, and surgical devices, all designed to address critical health needs. Bausch Health has achieved significant milestones, including strategic acquisitions that have bolstered its market position. The company continues to be a leader in the healthcare sector, dedicated to enhancing the quality of life for patients worldwide.
DitchCarbon Score
How does Bausch Health Cos's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bausch Health Cos's score of 36 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Bausch Health Cos's reported carbon emissions
In 2023, Bausch Health Cos reported total carbon emissions of approximately 65,518,000 kg CO2e from Scope 2 and 49,906,000 kg CO2e from Scope 1, alongside Scope 3 emissions of about 38,011,000 kg CO2e from purchased goods and services. This reflects a commitment to transparency in their emissions reporting, covering all three scopes of emissions. Comparatively, in 2022, the company recorded emissions of about 64,814,000 kg CO2e from Scope 2 and 46,686,000 kg CO2e from Scope 1, indicating a slight increase in emissions in 2023. The Scope 3 emissions for 2022 were not specified, but the company has shown a focus on various categories, including capital goods and waste generated in operations. Bausch Health has not publicly committed to specific reduction targets or initiatives, which may limit their ability to demonstrate a proactive approach to climate change mitigation. However, their ongoing emissions tracking suggests an awareness of their environmental impact. The company is headquartered in California and operates within an industry increasingly scrutinised for its carbon footprint, highlighting the importance of robust climate commitments moving forward.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Get Started| 2016 | 2018 | 2019 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 547,180,000 | 000,000,000 | - | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | - | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | 000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bausch Health Cos is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
